EUVIMEDEUVIMED entdecken
Open Access

Efficacy of vincristine as a rescue therapy for canine histiocytic sarcoma

Hiroki Sakuma, Akiyoshi Tani, Yuko Goto-Koshino, Aki Ohmi, Hajime Tsujimoto, Hirotaka Tomiyasu

Journal of Veterinary Medical Science · 2024

DOI: 10.1292/jvms.24-0218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Medical Science, 2024. Verfasst von Hiroki Sakuma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The Univers…. Hauptthemen laut MEDLINE: Histiocytic Sarcoma, Dog Diseases, Vincristine, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canine histiocytic sarcoma (CHS) is a malignant tumor derived from macrophages and dendritic cells. Since effective chemotherapy is needed for CHS cases, we conducted this prospective study to evaluate the efficacy and adverse events of vincristine treatment as a rescue therapy for this disease. We administered vincristine to nine CHS cases that acquired resistance to lomustine or nimustine. Complete remission was achieved in one dog, partial remission in two dogs, stable disease in five dogs, and progressive disease in one dog. The median progression-free survival was 21 days (range: 7-71 days). Severe adverse effect was observed in one dog (Grade 3 thrombocytopenia). It is essential to establish novel effective treatments for CHS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histiocytic SarcomaDog DiseasesVincristineAntineoplastic Agents, PhytogenicDogsAnimalsMaleFemaleLomustineProspective StudiesDrug Resistance, NeoplasmNimustine

Stichwörter der Autor:innen

chemotherapydoghistiocytic sarcomavincristine

Substanzen

VincristineAntineoplastic Agents, PhytogenicLomustineNimustine

Autor:innen und Institutionen

  • Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
  • Veterinary Medical Center, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Sakuma, H., Tani, A., Goto-Koshino, Y., Ohmi, A., Tsujimoto, H., & Tomiyasu, H. (2024). Efficacy of vincristine as a rescue therapy for canine histiocytic sarcoma. Journal of Veterinary Medical Science. https://doi.org/10.1292/jvms.24-0218

Vancouver

Sakuma H, Tani A, Goto-Koshino Y, Ohmi A, Tsujimoto H, Tomiyasu H. Efficacy of vincristine as a rescue therapy for canine histiocytic sarcoma. Journal of Veterinary Medical Science. 2024. doi:10.1292/jvms.24-0218

BibTeX
@article{Sakuma2024,
  author = {Sakuma, Hiroki and Tani, Akiyoshi and Goto-Koshino, Yuko and Ohmi, Aki and Tsujimoto, Hajime and Tomiyasu, Hirotaka},
  title = {Efficacy of vincristine as a rescue therapy for canine histiocytic sarcoma},
  journal = {Journal of Veterinary Medical Science},
  year = {2024},
  doi = {10.1292/jvms.24-0218}
}
Kostenlos starten →